NICE-recommended tumour profiling tests could prevent some breast cancer chemotherapy HighlightsHighlights Archive

NICE-recommended tumour profiling tests could prevent some breast cancer chemotherapy

NICE’s independent diagnostic advisory committee reviewed the evidence behind tumour profiling tests which are designed to provide information on the genetic makeup of breast cancer tumours. This information can be used to guide the treatment of women who have been through the menopause, and men, with oestrogen receptor (ER) or progesterone receptor (PR)-positive, human epidermal growth factor receptor 2 (HER2)-negative…
Ben Kemp
May 14, 2024
Media Monitoring: 2 – 8 May HighlightsHighlights Archive

Media Monitoring: 2 – 8 May

New blood test shows promise in early detection of ovarian cancer Epithelial ovarian cancer (EOC) accounts for the most significant number of deaths from female reproductive system cancers. A new paper published in the British Journal of Cancer explores the potential utility of glycoproteins as biomarkers of EOC. In the future, these types of models might allow the diagnosis of…
Ben Kemp
May 7, 2024
New screening trial to save thousands of men’s lives from prostate cancer HighlightsHighlights Archive

New screening trial to save thousands of men’s lives from prostate cancer

Thousands more men could be saved every year as a new screening trial aims to double the efficacy of prostate cancer screening. The £42m trial called TRANSFORM aims to find the best way to screen men for prostate cancer and is co-funded by Prostate Cancer UK and NIHR. The Government is investing £16m for the trial through NIHR. Movember is providing £1.5m funding, and…
Ben Kemp
May 7, 2024
ONS says UK R&D may be worth far more than currently estimated HighlightsHighlights Archive

ONS says UK R&D may be worth far more than currently estimated

Early findings from a revamped Office for National Statistics survey published suggest that the value of research and development undertaken in Britain each year could be more than 20% higher than estimates currently show. According to the redeveloped Business Enterprise Research and Development Survey, R&D expenditure in 2022 amounted to £53 billion pounds, compared with an existing estimate of £43.4 billion pounds…
Ben Kemp
May 7, 2024
Study highlights increased risk of second cancers among breast cancer survivors HighlightsHighlights Archive

Study highlights increased risk of second cancers among breast cancer survivors

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England. For the first time, the research has shown that this risk is higher in people living in areas of greater socioeconomic deprivation. Breast…
Ben Kemp
April 29, 2024
HDR UK and GA4GH form a strategic partnership to unite genomic and health data HighlightsHighlights Archive

HDR UK and GA4GH form a strategic partnership to unite genomic and health data

Health Data Research UK (HDR UK), the UK's national institute for health data science, and the Global Alliance for Genomics and Health (GA4GH) have announced a strategic partnership to expand existing open standards work and collaborate in the wider health data space. Together, both organisations plan to learn from global partners and promote adoption of health data related standards around the…
Ben Kemp
April 29, 2024
New £10.4M rare kidney disease research centre to pioneer new tests treatments HighlightsHighlights Archive

New £10.4M rare kidney disease research centre to pioneer new tests treatments

Thousands of people living with rare kidney disease will get access to improved diagnostics, treatments and potentially cures, thanks to the creation of a new research centre co-funded by Kidney Research UK and medical charity LifeArc. It will be led by experts from Alder Hey Children’s NHS Foundation Trust and the University of Liverpool. The LifeArc-Kidney Research UK Centre for Rare…
Ben Kemp
April 23, 2024
Genomics in Scotland: Building our Future strategy released HighlightsHighlights Archive

Genomics in Scotland: Building our Future strategy released

The Scottish Government have released their 'Genomics in Scotland: Building our Future strategy', which establishes their commitment to the development of a robust and sustainable national genomic medicine service. The initial implementation plan will focus on the foundational and preparatory work needed, in collaboration with stakeholders across Scotland, to ensure that investment and partnership working is targeted to benefit those that…
Ben Kemp
April 23, 2024